Objective: To assess the quality, readability, and actionability of hypertension patient education materials generated by six selected patient-facing large language model (LLM) platforms, and to characterize cross-platform heterogeneity to guide the optimization of AI-generated patient education materials. Methods: Six publicly accessible or commonly accessible platforms were evaluated using standardized prompts to generate patient education materials. Understandability and actionability were assessed using the Patient Education Materials Assessment Tool for Printable Materials (PEMAT-P). Information quality was evaluated using the expanded Ensuring Quality Information for Patients scale (EQIP-36), and overall quality was rated using the Global Quality Score (GQS). Readability was compared using seven metrics, including the Flesch Reading Ease Score (FRES) and the Flesch–Kincaid Grade Level (FKGL). Results: Overall educational quality and understandability were generally favorable, but substantial cross-platform heterogeneity was observed. Readability remained challenging, with low FRES values and grade-level indices generally exceeding commonly recommended thresholds for patient education materials. Qwen3-Max-Thinking-Preview achieved the highest PEMAT-P total score (77.00), followed by ChatGPT 5.2-Thinking (72.22). For EQIP-36, Qwen3-Max-Thinking-Preview scored highest (49.28), followed by DeepSeek-R1 (45.48). DeepSeek-R1 generated the most readable materials among the evaluated platforms, with a median FRES of approximately 42.14 and FKGL of approximately 10.10, whereas Qwen3-Max-Thinking-Preview showed lower readability, with a median FRES of approximately 16.82 and FKGL of approximately 14.38. Kimi K2 showed high PEMAT-P understandability (76.90) but low actionability (10.00). Post hoc analyses showed that Qwen3-Max-Thinking-Preview significantly outperformed ERNIE Bot 4.5 Turbo, Doubao, and Kimi K2 on PEMAT-P total score, and outperformed Kimi K2 and ERNIE Bot 4.5 Turbo on EQIP-36. DeepSeek-R1 also outperformed Kimi K2 and ERNIE Bot 4.5 Turbo on EQIP-36. Across content domains, actionability was significantly higher for Daily Care and Prevention than for Basic Understanding of the Disease and Complications, Psychological and Social Aspects. Conclusions: Generative AI shows promise for hypertension patient education, particularly in improving understandability. However, actionability remains a major limitation of current outputs, highlighting the need for platform-aware optimization strategies that explicitly strengthen step-by-step and action-oriented guidance.
10 June 2026 in Frontiers in Cardiovascular Medicine
Background: Patients with cardiac myxoma require long-term follow-up, and the quality of patient education as well as the ability to recognize early symptoms may influence integrated postoperative cardiovascular and tumor-related management. Although large language models (LLMs) have been increasingly applied in medical education, cross-platform empirical evidence in this intersecting context remains limited. This study evaluated the performance and limitations of widely used LLMs in generating patient education texts for cardiac myxoma using a standardized, expert-curated educational question set. Methods: We constructed a standardized dataset of 60 expert-curated educational questions spanning the disease course of cardiac myxoma and used nine widely used LLMs to generate 540 patient education texts. Text quality, readability, and actionability were assessed using the Patient Education Materials Assessment Tool for Printable Materials (PEMAT-P), Ensuring Quality Information for Patients (EQIP-36), the Global Quality Score (GQS), and seven readability formulas. In addition, a regularized Gaussian graphical model-based partial correlation network analysis and latent profile analysis were performed to identify relationships among evaluation metrics and cross-platform text phenotypes. Results: Texts generated across platforms showed significant heterogeneity in information quality, understandability, and objective readability, whereas clinical actionability was generally low. Word count showed the strongest positive correlation with the total EQIP-36 score and occupied a central position in the network. Reading-difficulty indices were consistently negatively correlated with PEMAT-P actionability. Latent profile analysis identified three text phenotypes: moderate-quality/low-readability, high-quality/high-actionability, and low-quality/easy-to-read. Ideally suited patient education texts accounted for only a very small proportion of all outputs. Conclusions: Within this expert-curated educational question set, the current application of LLMs in patient education for cardiac myxoma is primarily limited by reading burden and insufficient behavioral guidance. Although longer outputs were generally associated with higher informational quality scores, greater syntactic complexity was associated with lower actionability of the materials. In addition, latent profile analysis suggested that only a small subset of outputs approached a more favorable quality–actionability profile.
1 March 2020 in Biochemical and Biophysical Research Communications
Background. Women hospitalized with ST-elevation myocardial infarction (STEMI) experience higher risk of early mortality than men. We aimed to investigate the potential impact of risk factors, clinical characteristics, and management among gender-related risk differences. Method. We analyzed 5063 STEMI patients prospectively enrolled from 66 hospitals during 2016–2018 and compared sex differences in mortality, death, or treatment withdrawal and main adverse cardiovascular and cerebrovascular events (MACCE) using the generalized linear mixed model, following sequential adjustment for covariates. Results. Women were older and had a higher prevalence of hypertension (53.3% vs. 41.1%, ) and diabetes (24.5% vs. 15.2%, ). Eligible women were less likely to receive reperfusion therapy (56.1% vs. 62.4%, ); the onset to first medical contact (FMC) (255 vs. 190 minutes, ), onset to fibrinolysis (218 vs. 185 minutes, ), and onset to percutaneous coronary intervention (PCI) (307 vs. 243 minutes, ) were significantly delayed in women. The incidence of in-hospital death (6.8% vs. 3.0%, ), death or treatment withdrawal (14.5% vs. 5.6%, ), and MACCE (18.5% vs. 9.4%, ) were notably higher. The gender disparities persist in death (OR: 1.61, 95% CI: 1.12–2.33), death or treatment withdrawal (OR: 1.68, 95% CI: 1.26–2.24), and MACCE (OR: 1.37, 95% CI: 1.08–1.74) after adjustment for covariates. Among possible explanatory factors, age (−58.46%, −59.04%, −62.20%) and cardiovascular risk factors (−40.77%, −39.36%, −41.73%) accounted for most of the gender-associated risk differences. Conclusions. Women experienced worse in-hospital outcomes, and age and cardiovascular risk factors were major factors influencing sex-related differences. The sex disparity stressed the awareness and importance of quality improvement efforts against female patients in clinical practice.
Background: Insomnia is a prevalent sleep disorder increasingly recognized as a risk factor for cardiovascular diseases (CVDs). However, its causal relationship with myocardial infarction (MI) and its impact on coronary plaque vulnerability remain poorly understood. Methods: We performed Mendelian randomization (MR) analysis using genome‐wide association study (GWAS) summary data for insomnia ( n = 462,341) and MI ( n = 484,598) in populations of European descent. Additionally, 340 patients with coronary artery disease (CAD) underwent coronary angiography and optical coherence tomography (OCT) imaging. Insomnia was assessed by the Insomnia Severity Index (ISI), and OCT was used to evaluate plaque features including thin‐cap fibroatheroma (TCFA), fibrous cap thickness, lipid arc, macrophage infiltration, and plaque rupture. Results: MR analysis showed a potential causal effect of genetically predicted insomnia on MI risk (OR = 1.015; 95% CI: 1.004–1.027; p = 0.007), with no evidence of pleiotropy or heterogeneity. Clinically patients with insomnia (ISI ≥ 8) had higher rates of hypertension (54.3% vs. 39.6%) and MI (32.4% vs. 21.7%), elevated CRP levels, and exhibited greater plaque vulnerability on OCT, including increased incidence of TCFA (29.5% vs. 17.0%), thinner fibrous caps, larger lipid arcs, and more frequent macrophage infiltration and plaque rupture. Logistic regression identified both insomnia (OR = 1.806; p = 0.037) and CRP (OR = 1.384; p = 0.034) as independent predictors of TCFA. Conclusions: This study provides genetic and clinical evidence that insomnia contributes to MI risk and coronary plaque vulnerability, underscoring the importance of addressing sleep disturbances in CAD management.
20 August 2026 in Frontiers in Cardiovascular Medicine
Diabetic cardiomyopathy refers to myocardial structural, functional, and metabolic abnormalities enriched in people with diabetes that are not fully explained by obstructive epicardial coronary artery disease, significant valvular disease, or other established cardiac conditions. In clinical practice, diabetic myocardial dysfunction frequently overlaps with obesity, hypertension, chronic kidney disease, coronary microvascular dysfunction, and heart failure with preserved ejection fraction (HFpEF)-type cardiometabolic phenotypes. Among the mechanisms implicated in this condition, advanced glycation end products (AGEs) and receptor for advanced glycation end products (RAGE) signaling constitute a biologically plausible framework linking chronic hyperglycemia and dicarbonyl stress to myocardial injury. This review distinguishes RAGE-independent AGE-mediated injury, including extracellular matrix cross-linking and intracellular protein modification, from RAGE-dependent multiligand signaling, which may amplify oxidative, inflammatory, mitochondrial, calcium-handling, endothelial, and profibrotic responses. We further discuss RAGE as a multiligand pattern-recognition receptor and its interactions with danger signaling, innate immune pathways, and inflammasome activation within a broader inflammatory–oxidative network. In addition, we evaluate therapeutic strategies aimed at reducing glycation burden, interrupting matrix cross-linking, or inhibiting receptor-related signaling, and assess circulating and tissue-related biomarkers for phenotypic stratification and therapeutic monitoring. The review further considers methylglyoxal, glyoxal, 3-deoxyglucosone, and glyoxalase-1-dependent detoxification as components of dicarbonyl stress. Although experimental evidence supports biological plausibility, human evidence remains predominantly associative, circulating biomarkers lack cardiac specificity, and DCM-specific therapeutic trials are scarce. Future studies should use phenotype-enriched, multimodal biomarker strategies and mechanism-matched endpoints to determine whether selected patient subgroups may benefit from AGE- or RAGE-directed intervention.